Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ironwood Pharmaceuti (IRWD)

Ironwood Pharmaceuti (IRWD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,640,203
  • Shares Outstanding, K 160,962
  • Annual Sales, $ 389,520 K
  • Annual Income, $ 106,180 K
  • 60-Month Beta 1.41
  • Price/Sales 4.27
  • Price/Cash Flow 12.65
  • Price/Book 26.51
Trade IRWD with:

Options Overview

Details
  • Implied Volatility 116.07%
  • Historical Volatility 36.72%
  • IV Percentile 96%
  • IV Rank 63.48%
  • IV High 160.88% on 04/20/20
  • IV Low 38.19% on 01/21/21
  • Put/Call Vol Ratio 0.44
  • Today's Volume 39
  • Volume Avg (30-Day) 275
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 7,299
  • Open Int (30-Day) 9,947

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.21
  • Number of Estimates 4
  • High Estimate 0.33
  • Low Estimate 0.12
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +425.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.02 +1.40%
on 04/12/21
11.72 -13.27%
on 03/22/21
-1.15 (-10.21%)
since 03/12/21
3-Month
8.78 +15.69%
on 02/26/21
11.77 -13.68%
on 01/13/21
-1.55 (-13.24%)
since 01/12/21
52-Week
8.63 +17.73%
on 09/29/20
12.55 -19.04%
on 12/04/20
+0.41 (+4.21%)
since 04/09/20

Most Recent Stories

More News
Global Constipation Treatment Drug Market 2020 Applications, SWOT Analysis, Remarkable Growth and Competitive Landscape by 2025

aims to deliver wide-ranging information on the market by taking into account several aspects of marketing research and analysis which include market size estimations, market dynamics, positioning and...

ABT : 121.04 (+0.12%)
ALBO : 31.94 (-2.86%)
IRWD : 10.16 (-0.29%)
PBH : 44.30 (+1.26%)
SCMP : 18.05 (+0.28%)
SGYP : 0.03 (-52.00%)
VRX.TO : 30.80 (-3.33%)
AavantiBio Appoints Dr. Christopher Wright as Chief Medical Officer

AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, today announced the appointment of Christopher Wright, M.D., Ph.D., as Chief Medical Officer....

CYCN : 2.77 (-2.81%)
IRWD : 10.16 (-0.29%)
VRTX : 213.60 (+0.12%)
Ironwood (IRWD) Up 20.4% Since Last Earnings Report: Can It Continue?

Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IRWD : 10.16 (-0.29%)
3 Must-Own Undervalued Growth Stocks

While the growth stocks that skyrocketed over the past year have been experiencing a sell-off lately, there are a new set of stocks in the class that are poised to grow significantly with an economic recovery....

PHM : 54.10 (-0.84%)
TUP : 28.13 (+4.11%)
IRWD : 10.16 (-0.29%)
January 2022 Options Now Available For Ironwood Pharmaceuticals (IRWD)

Investors in Ironwood Pharmaceuticals Inc saw new options begin trading today, for the January 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the...

IRWD : 10.16 (-0.29%)
3 Growth Stocks to Scoop Up During the Next Market Sell-Off

The stock markets are experiencing a phase of volatility and uncertainty. Inflation fears and a potential tech bubble burst could precipitate a deep sell-off in the near-term. However, experts say that...

GFI : 9.47 (-4.15%)
SID : 7.58 (unch)
IRWD : 10.16 (-0.29%)
NeoGenomics Announces CEO Succession

Mark Mallon named CEO effective April 2021; Douglas M. VanOort will retire as CEO and transition to executive chairman of the board of directors

IRWD : 10.16 (-0.29%)
NEO : 48.91 (+1.54%)
Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, announced that management will be presenting at the following investor conferences:

IRWD : 10.16 (-0.29%)
Ironwood (IRWD) Q4 Earnings Beat on Solid Linzess Sales

Ironwood (IRWD) witnesses strong demand for Linzess in the fourth quarter. However, outlook for 2021 misses market expectations.

IRWD : 10.16 (-0.29%)
AZN : 49.42 (-1.04%)
ALNY : 135.03 (-2.31%)
ABBV : 108.25 (+0.66%)
Ironwood Pharmaceuticals (IRWD) Surpasses Q4 Earnings and Revenue Estimates

Ironwood (IRWD) delivered earnings and revenue surprises of 33.33% and 9.56%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

IRWD : 10.16 (-0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome...

See More

Key Turning Points

3rd Resistance Point 10.54
2nd Resistance Point 10.41
1st Resistance Point 10.28
Last Price 10.16
1st Support Level 10.03
2nd Support Level 9.90
3rd Support Level 9.77

See More

52-Week High 12.55
Fibonacci 61.8% 11.05
Fibonacci 50% 10.59
Last Price 10.16
Fibonacci 38.2% 10.13
52-Week Low 8.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar